广州瑞通生物科技有限公司
广州瑞通生物科技有限公司
DegronTherapeuticsaimstobecomeagloballeaderinthediscoveryanddevelopmentofanewclassoftargetedproteindegradationtherapeutics,smallmoleculemoleculargluedegrader(MGD)drugs.Degronhasassembledateamofworld-classexecutivesandscientificleaders,bringingitsscientificexcellencetotheidentificationandvalidationofdiseasetargets,particularlythoseundruggablebyconventionalsmallmoleculeinhibitors,andnovelselectiveMGDcompoundstomeetunmetmedicalneedsinalltherapeuticareas.